Home / Pharmaceutical / The Pharmaceutical Market: United Arab Emirates

The Pharmaceutical Market: United Arab Emirates

Published: Jul 2014 | No Of Pages: 127 | Published By: Espicom

Product Synopsis

 
OVERVIEW OF THE PHARMACEUTICAL MARKET IN UNITED ARAB EMIRATES
 
The United Arab Emirates'healthcare and pharmaceutical markets continue to be thestrongest in the region.Its growth prospects arestrong -we forecast high single-digit CAGRsover the course of our 10-year forecast period. Several factors are driving growth: incomes are high, as isthe UAE's expatriate population.These elements combine to increase private healthcare expenditure and demand for innovative drugs.
 
Local drug production facilities are also gaining strength, with domestic player Julphar opening a new factory, and multinational drug firms are also entering the market. In addition, there areplans forseveral new hospital and healthcare facilities,whichwill boost future demand for pharmaceuticals. The UAE's appeal as a medical tourism destination is another driver of growth.Wethereforeremain optimistic aboutthegrowth potentialof the United Arab Emirates (UAE)'spharmaceuticalandhealthcaremarkets.
 
Headline Expenditure Projections
 
  • Pharmaceuticals: AED5.56bn (US$1.51bn) in 2011 to AED5.72bn (US$1.56bn) in 2012; +2.9% in local currency and US dollar terms. Forecastunchanged from Q412.
  • Healthcare: AED46.44bn (US$12.64bn) in 2011 to AED52.13bn (US$14.20bn) in 2012; +12.2% in local currency terms and +12.3% in US dollar terms. Forecastbroadly unchanged from Q412.
  • Medical devices: AED1.87bn (US$508mn) in 2011 to AED2.05bn (US$559mn) in 2012; +10.0% in local currency terms and +10.1% in US dollar terms. Forecastbroadly unchanged from Q412.
Business Environment Rating
 
In Q1 13, the UAE remains the most attractive market in BMI's Middle East and Africa (MEA) Pharmaceutical Risk/Reward Ratings (RRR) matrix, with its composite score unchanged at 58.3 out of 100. The country has a favourable medium-term pharmaceutical market growth forecast.
 
Competitive Landscape
 
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
BMI Industry View7
SWOT9
Business Environment11
Economic12
Political13
Industry Forecast14
Pharmaceutical Market Forecast14
 
Table: Pharmaceutical Sales Indicators 2009-201715
 
Healthcare Market Forecast16
 
Table: Healthcare Expenditure Indicators 2009-201718
Table: Healthcare Governmental Indicators 2009-201718
Table: Healthcare Private Indicators 2009-201719
 
Prescription Market Forecast19
 
Table: UAE Healthcare Demand Split By Therapeutic Area20
Table: Prescription Drug Sales Indicators 2009-201722
 
Patented Drug Market Forecast22
 
Table: Patented Drug Market Indicators, 2009-201723
 
Generic Drug Market Forecast23
 
Table: Generic Drug Sales Indicators, 2009-201724
 
OTC Medicine Market Forecast25
 
Table: OTC Medicine Sales Indicators, 2009-201726
 
Pharmaceutical Trade Forecast27
 
Table: Exports And Imports Indicators, 2009-201728
 
Other Healthcare Data28
Key Risks To BMI's Forecast Scenario30
Macroeconomic Forecasts31
Economic Analysis31
Dubai: Confident As Ever31
Oman: An Exciting Time34
Industry Risk Reward Ratings36
 
Table: Pharmaceuticals & Healthcare Risk/Reward Ratings, Q21336
 
Rewards37
Risks38
Market Overview40
Macroeconomic Forecasts42
Economic Analysis42
Dubai: Confident As Ever42
Oman: An Exciting Time45
Industry Trends And Developments47
Epidemiology47
 
Table: UAE Healthcare Demand Split By Therapeutic Area48
 
Healthcare Sector52
Healthcare Sector Developments53
Health Insurance58
Research & Development63
Regulatory Development65
Regulatory Regime65
Regulatory Developments66
Pharmacovigilance67
Pharmaceutical Advertising68
Intellectual Property Issues68
Pricing Regime70
Pricing And Reimbursement Developments71
Regional Harmonisation74
Competitive Landscape77
Pharmaceutical Sector77
 
Table: Abu Dhabi's Top Five Best Selling Drugs In Value Terms By Therapeutic Area77
Domestic Industry78
Foreign Industry79
Recent Company Developments80
Pharmaceutical Distribution And Retail81
Recent Developments82
Company Profile84
Julphar84
Modern Pharmaceutical Company88
Neopharma90
Medpharma93
GlaxoSmithKline95
Pfizer97
Novartis99
Johnson & Johnson101
Sanofi Aventis103
Abbott105
Merck & Co107
Demographic Forecast109
 
Table: United Arab Emirates' Population By Age Group, 1990-2020 ('000)110
Table: United Arab Emirates' Population By Age Group, 1990-2020111
Table: United Arab Emirates' Key Population Ratios, 1990-2020112
Table: United Arab Emirates' Rural And Urban Population, 1990-2020112
 
Glossary113
Methodology115
Methodology115
Risk/Reward Ratings Methodology115
Ratings Overview116
 
Table: Pharmaceutical Business Environment Indicators116
 
Weighting117
 
Table: Weighting Of Components117
 
Sources117
Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +